fanta.bio Sample: CNhs11856
24318 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1272 / 16805 (7.6%) | 396 / 168050 (0.2%) | −324.0 | −324.0 | 32.12 |
| TP53 SRX19538274 | U2OS Bone | 467 / 16805 (2.8%) | 162 / 168050 (0.1%) | −324.0 | −324.0 | 28.83 |
| TP53 SRX19538268 | U2OS Bone | 463 / 16805 (2.8%) | 164 / 168050 (0.1%) | −324.0 | −324.0 | 28.23 |
| HIF1A SRX11007095 | HK-2 Kidney | 2378 / 16805 (14.2%) | 869 / 168050 (0.5%) | −324.0 | −324.0 | 27.36 |
| TP53 SRX19538276 | U2OS Bone | 457 / 16805 (2.7%) | 174 / 168050 (0.1%) | −324.0 | −324.0 | 26.26 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 490 / 16805 (2.9%) | 192 / 168050 (0.1%) | −324.0 | −324.0 | 25.52 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1827 / 16805 (10.9%) | 737 / 168050 (0.4%) | −324.0 | −324.0 | 24.79 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1783 / 16805 (10.6%) | 743 / 168050 (0.4%) | −324.0 | −324.0 | 24.00 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2510 / 16805 (14.9%) | 1053 / 168050 (0.6%) | −324.0 | −324.0 | 23.84 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2569 / 16805 (15.3%) | 1087 / 168050 (0.6%) | −324.0 | −324.0 | 23.63 |
| SCML2 SRX644728 | 293 Kidney | 1590 / 16805 (9.5%) | 678 / 168050 (0.4%) | −324.0 | −324.0 | 23.45 |
| HIF1A SRX20663235 | HK-2 Kidney | 539 / 16805 (3.2%) | 242 / 168050 (0.1%) | −324.0 | −324.0 | 22.27 |
| TP53 SRX19538279 | Osteoblasts Bone | 559 / 16805 (3.3%) | 270 / 168050 (0.2%) | −324.0 | −324.0 | 20.70 |
| FOXP1 SRX736067 | LNCAP Prostate | 1978 / 16805 (11.8%) | 1096 / 168050 (0.7%) | −324.0 | −324.0 | 18.05 |
| MYH11 SRX265221 | ME-1 Blood | 961 / 16805 (5.7%) | 587 / 168050 (0.3%) | −324.0 | −324.0 | 16.37 |
| BRD4 SRX9419935 | BT-474 Breast | 3518 / 16805 (20.9%) | 2811 / 168050 (1.7%) | −324.0 | −324.0 | 12.52 |
| MED1 SRX9419944 | BT-474 Breast | 3460 / 16805 (20.6%) | 2783 / 168050 (1.7%) | −324.0 | −324.0 | 12.43 |
| MED1 SRX9419945 | BT-474 Breast | 3517 / 16805 (20.9%) | 2844 / 168050 (1.7%) | −324.0 | −324.0 | 12.37 |
| MED1 SRX9419946 | BT-474 Breast | 3587 / 16805 (21.3%) | 2969 / 168050 (1.8%) | −324.0 | −324.0 | 12.08 |
| BRD4 SRX9419936 | BT-474 Breast | 3553 / 16805 (21.1%) | 2957 / 168050 (1.8%) | −324.0 | −324.0 | 12.02 |
| BRD4 SRX9419937 | BT-474 Breast | 3459 / 16805 (20.6%) | 2887 / 168050 (1.7%) | −324.0 | −324.0 | 11.98 |
| BRD4 SRX9419938 | BT-474 Breast | 3531 / 16805 (21.0%) | 2980 / 168050 (1.8%) | −324.0 | −324.0 | 11.85 |
| MED1 SRX9419947 | BT-474 Breast | 3474 / 16805 (20.7%) | 2932 / 168050 (1.7%) | −324.0 | −324.0 | 11.85 |
| EZH2 SRX2146136 | LNCAP Prostate | 8041 / 16805 (47.8%) | 7995 / 168050 (4.8%) | −324.0 | −324.0 | 10.06 |
| BRD4 SRX736201 | 90-8TL Neural | 6094 / 16805 (36.3%) | 6503 / 168050 (3.9%) | −324.0 | −324.0 | 9.37 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1921 / 16805 (11.4%) | 2608 / 168050 (1.6%) | −324.0 | −324.0 | 7.37 |
| TP53 SRX19538280 | Osteoblasts Bone | 450 / 16805 (2.7%) | 199 / 168050 (0.1%) | −306.8 | −303.7 | 22.61 |
| TP53 SRX19538267 | U2OS Bone | 414 / 16805 (2.5%) | 146 / 168050 (0.1%) | −300.9 | −297.8 | 28.36 |
| TP53 SRX19538275 | U2OS Bone | 420 / 16805 (2.5%) | 163 / 168050 (0.1%) | −297.4 | −294.4 | 25.77 |
| TP53 SRX19538273 | U2OS Bone | 405 / 16805 (2.4%) | 146 / 168050 (0.1%) | −292.6 | −289.6 | 27.74 |
| TP53 SRX19538281 | Osteoblasts Bone | 471 / 16805 (2.8%) | 309 / 168050 (0.2%) | −279.6 | −276.6 | 15.24 |
| BRD4 SRX736204 | 90-8TL Neural | 1114 / 16805 (6.6%) | 2762 / 168050 (1.6%) | −275.0 | −272.0 | 4.03 |
| TP53 SRX19538269 | U2OS Bone | 502 / 16805 (3.0%) | 426 / 168050 (0.3%) | −266.5 | −263.5 | 11.78 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 657 / 16805 (3.9%) | 914 / 168050 (0.5%) | −263.7 | −260.7 | 7.19 |
| IRF3 SRX11453858 | Hep G2 Liver | 330 / 16805 (2.0%) | 78 / 168050 (0.0%) | −262.9 | −260.0 | 42.31 |
| AR SRX10820653 | LNCAP Prostate | 387 / 16805 (2.3%) | 191 / 168050 (0.1%) | −254.7 | −251.7 | 20.26 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1255 / 16805 (7.5%) | 3711 / 168050 (2.2%) | −252.7 | −249.7 | 3.38 |
| FOXA1 SRX4815198 | MCF-7 Breast | 989 / 16805 (5.9%) | 24221 / 168050 (14.4%) | −249.3 | −246.3 | 0.41 |
| TP53 SRX19538270 | U2OS Bone | 479 / 16805 (2.9%) | 428 / 168050 (0.3%) | −247.9 | −245.0 | 11.19 |
| AGO2 SRX4708039 | Hep G2 Liver | 1872 / 16805 (11.1%) | 7419 / 168050 (4.4%) | −246.9 | −243.9 | 2.52 |
| ESR1 SRX7624157 | MCF-7 Breast | 751 / 16805 (4.5%) | 20477 / 168050 (12.2%) | −242.7 | −239.8 | 0.37 |
| ESR1 SRX4367193 | MCF-7 Breast | 975 / 16805 (5.8%) | 23557 / 168050 (14.0%) | −236.4 | −233.5 | 0.41 |
| ESR1 SRX20282961 | MCF-7 Breast | 336 / 16805 (2.0%) | 13489 / 168050 (8.0%) | −235.8 | −232.9 | 0.25 |
| FOXA1 SRX4815197 | MCF-7 Breast | 730 / 16805 (4.3%) | 19798 / 168050 (11.8%) | −232.1 | −229.3 | 0.37 |
| ESR1 SRX371469 | MCF-7 Breast | 273 / 16805 (1.6%) | 12167 / 168050 (7.2%) | −230.1 | −227.3 | 0.22 |
| PBX4 SRX2731658 | PC-3 Prostate | 1186 / 16805 (7.1%) | 26274 / 168050 (15.6%) | −229.7 | −226.8 | 0.45 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 630 / 16805 (3.7%) | 1003 / 168050 (0.6%) | −229.6 | −226.8 | 6.28 |
| ESR1 SRX371478 | MCF-7 Breast | 357 / 16805 (2.1%) | 13671 / 168050 (8.1%) | −229.4 | −226.6 | 0.26 |
| ESR1 SRX7624156 | MCF-7 Breast | 456 / 16805 (2.7%) | 15336 / 168050 (9.1%) | −228.4 | −225.6 | 0.30 |
| FOXA1 SRX176862 | MCF-7 Breast | 379 / 16805 (2.3%) | 13938 / 168050 (8.3%) | −225.6 | −222.8 | 0.27 |
| FOXA1 SRX176863 | MCF-7 Breast | 346 / 16805 (2.1%) | 13342 / 168050 (7.9%) | −224.9 | −222.1 | 0.26 |
| IRF3 SRX11453861 | Hep G2 Liver | 291 / 16805 (1.7%) | 81 / 168050 (0.0%) | −224.0 | −221.2 | 35.93 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 334 / 16805 (2.0%) | 13008 / 168050 (7.7%) | −221.0 | −218.2 | 0.26 |
| ESR1 SRX176861 | MCF-7 Breast | 490 / 16805 (2.9%) | 15635 / 168050 (9.3%) | −220.3 | −217.5 | 0.31 |
| TP53 SRX19538282 | Osteoblasts Bone | 406 / 16805 (2.4%) | 330 / 168050 (0.2%) | −219.8 | −217.0 | 12.30 |
| ESR1 SRX176860 | MCF-7 Breast | 490 / 16805 (2.9%) | 15563 / 168050 (9.3%) | −218.2 | −215.4 | 0.31 |
| ESR1 SRX20282960 | MCF-7 Breast | 322 / 16805 (1.9%) | 12704 / 168050 (7.6%) | −218.1 | −215.4 | 0.25 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 335 / 16805 (2.0%) | 12916 / 168050 (7.7%) | −217.5 | −214.7 | 0.26 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 443 / 16805 (2.6%) | 14625 / 168050 (8.7%) | −213.0 | −210.2 | 0.30 |
| FOXA1 SRX371483 | MCF-7 Breast | 331 / 16805 (2.0%) | 12704 / 168050 (7.6%) | −212.8 | −210.1 | 0.26 |
| FOXA1 SRX371481 | MCF-7 Breast | 304 / 16805 (1.8%) | 12222 / 168050 (7.3%) | −212.8 | −210.0 | 0.25 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 885 / 16805 (5.3%) | 2254 / 168050 (1.3%) | −211.0 | −208.3 | 3.93 |
| ESR1 SRX20282939 | MCF-7 Breast | 334 / 16805 (2.0%) | 12656 / 168050 (7.5%) | −209.5 | −206.8 | 0.26 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 532 / 16805 (3.2%) | 15922 / 168050 (9.5%) | −208.5 | −205.8 | 0.33 |
| FOXA1 SRX1161177 | MCF-7 Breast | 303 / 16805 (1.8%) | 12029 / 168050 (7.2%) | −207.0 | −204.3 | 0.25 |
| FOXA1 SRX3931044 | MCF-7 Breast | 688 / 16805 (4.1%) | 18290 / 168050 (10.9%) | −207.0 | −204.3 | 0.38 |
| ESR1 SRX371467 | MCF-7 Breast | 304 / 16805 (1.8%) | 12046 / 168050 (7.2%) | −207.0 | −204.3 | 0.25 |
| ESR1 SRX194569 | MCF-7 Breast | 301 / 16805 (1.8%) | 11984 / 168050 (7.1%) | −206.7 | −204.0 | 0.25 |
| Epitope tags SRX10549776 | K-562 Blood | 1393 / 16805 (8.3%) | 5110 / 168050 (3.0%) | −206.2 | −203.5 | 2.73 |
| ESR1 SRX1531791 | MCF-7 Breast | 279 / 16805 (1.7%) | 11555 / 168050 (6.9%) | −205.8 | −203.1 | 0.24 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 279 / 16805 (1.7%) | 11545 / 168050 (6.9%) | −205.5 | −202.8 | 0.24 |
| GATA3 SRX190239 | MCF-7 Breast | 459 / 16805 (2.7%) | 14613 / 168050 (8.7%) | −204.4 | −201.8 | 0.31 |
| AR SRX10820651 | LNCAP Prostate | 381 / 16805 (2.3%) | 316 / 168050 (0.2%) | −204.3 | −201.6 | 12.06 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 582 / 16805 (3.5%) | 979 / 168050 (0.6%) | −203.3 | −200.6 | 5.94 |
| TP53 SRX19538271 | U2OS Bone | 649 / 16805 (3.9%) | 1248 / 168050 (0.7%) | −203.2 | −200.5 | 5.20 |
| TLE3 SRX4815191 | MCF-7 Breast | 289 / 16805 (1.7%) | 11646 / 168050 (6.9%) | −202.7 | −200.1 | 0.25 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 451 / 16805 (2.7%) | 14321 / 168050 (8.5%) | −199.5 | −196.9 | 0.31 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1392 / 16805 (8.3%) | 5211 / 168050 (3.1%) | −199.4 | −196.8 | 2.67 |
| FOXA1 SRX1161176 | MCF-7 Breast | 293 / 16805 (1.7%) | 11571 / 168050 (6.9%) | −197.9 | −195.3 | 0.25 |
| ESR1 SRX371476 | MCF-7 Breast | 219 / 16805 (1.3%) | 10193 / 168050 (6.1%) | −197.7 | −195.1 | 0.21 |
| ESR1 SRX371479 | MCF-7 Breast | 282 / 16805 (1.7%) | 11338 / 168050 (6.7%) | −196.8 | −194.2 | 0.25 |
| ESR1 SRX20282954 | MCF-7 Breast | 334 / 16805 (2.0%) | 12240 / 168050 (7.3%) | −196.2 | −193.6 | 0.27 |
| ESR1 SRX371468 | MCF-7 Breast | 180 / 16805 (1.1%) | 9342 / 168050 (5.6%) | −194.6 | −192.0 | 0.19 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 228 / 16805 (1.4%) | 10257 / 168050 (6.1%) | −194.0 | −191.4 | 0.22 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 657 / 16805 (3.9%) | 1351 / 168050 (0.8%) | −193.7 | −191.1 | 4.86 |
| ESR1 SRX371471 | ZR-75-1 Breast | 338 / 16805 (2.0%) | 12228 / 168050 (7.3%) | −193.5 | −190.9 | 0.28 |
| ESR1 SRX20282972 | MCF-7 Breast | 348 / 16805 (2.1%) | 12391 / 168050 (7.4%) | −193.3 | −190.7 | 0.28 |
| ESR1 SRX10365535 | MCF-7 Breast | 232 / 16805 (1.4%) | 10269 / 168050 (6.1%) | −191.9 | −189.4 | 0.23 |
| ESR1 SRX194572 | MCF-7 Breast | 181 / 16805 (1.1%) | 9287 / 168050 (5.5%) | −191.9 | −189.3 | 0.19 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 281 / 16805 (1.7%) | 11168 / 168050 (6.6%) | −191.8 | −189.3 | 0.25 |
| FOXA1 SRX1161173 | MCF-7 Breast | 242 / 16805 (1.4%) | 10450 / 168050 (6.2%) | −191.6 | −189.0 | 0.23 |
| ESR1 SRX10365536 | MCF-7 Breast | 137 / 16805 (0.8%) | 8368 / 168050 (5.0%) | −191.4 | −188.9 | 0.16 |
| FOXA1 SRX371482 | MCF-7 Breast | 484 / 16805 (2.9%) | 14569 / 168050 (8.7%) | −190.9 | −188.4 | 0.33 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 281 / 16805 (1.7%) | 11128 / 168050 (6.6%) | −190.5 | −187.9 | 0.25 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 273 / 16805 (1.6%) | 112 / 168050 (0.1%) | −190.3 | −187.7 | 24.38 |
| ESR1 SRX371470 | ZR-75-1 Breast | 284 / 16805 (1.7%) | 11156 / 168050 (6.6%) | −189.7 | −187.2 | 0.25 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 279 / 16805 (1.7%) | 11069 / 168050 (6.6%) | −189.7 | −187.2 | 0.25 |
| KAT7 SRX101303 | RKO Digestive tract | 1342 / 16805 (8.0%) | 5067 / 168050 (3.0%) | −189.3 | −186.7 | 2.65 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 894 / 16805 (5.3%) | 20551 / 168050 (12.2%) | −186.7 | −184.2 | 0.44 |
| BMI1 SRX644729 | 293 Kidney | 273 / 16805 (1.6%) | 127 / 168050 (0.1%) | −183.1 | −180.6 | 21.50 |
| GATA3 SRX5057632 | MCF-7 Breast | 196 / 16805 (1.2%) | 9316 / 168050 (5.5%) | −182.8 | −180.3 | 0.21 |
| FOXA1 SRX1161175 | MCF-7 Breast | 240 / 16805 (1.4%) | 10121 / 168050 (6.0%) | −182.0 | −179.5 | 0.24 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 430 / 16805 (2.6%) | 13375 / 168050 (8.0%) | −181.3 | −178.8 | 0.32 |
| ESR1 SRX20282955 | MCF-7 Breast | 339 / 16805 (2.0%) | 11852 / 168050 (7.1%) | −181.1 | −178.6 | 0.29 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1024 / 16805 (6.1%) | 22131 / 168050 (13.2%) | −180.8 | −178.3 | 0.46 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 778 / 16805 (4.6%) | 18633 / 168050 (11.1%) | −180.0 | −177.5 | 0.42 |
| BRD1 SRX286203 | RKO Digestive tract | 1159 / 16805 (6.9%) | 4109 / 168050 (2.4%) | −180.0 | −177.5 | 2.82 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 325 / 16805 (1.9%) | 11567 / 168050 (6.9%) | −179.7 | −177.3 | 0.28 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 647 / 16805 (3.9%) | 1417 / 168050 (0.8%) | −179.7 | −177.2 | 4.57 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 248 / 16805 (1.5%) | 10187 / 168050 (6.1%) | −179.3 | −176.8 | 0.24 |
| ESR1 SRX20282973 | MCF-7 Breast | 398 / 16805 (2.4%) | 12770 / 168050 (7.6%) | −178.8 | −176.4 | 0.31 |
| ESR1 SRX2881000 | MCF-7 Breast | 275 / 16805 (1.6%) | 10652 / 168050 (6.3%) | −178.5 | −176.1 | 0.26 |
| FOXA1 SRX1161174 | MCF-7 Breast | 341 / 16805 (2.0%) | 11790 / 168050 (7.0%) | −178.2 | −175.7 | 0.29 |
| ESR1 SRX20282940 | MCF-7 Breast | 358 / 16805 (2.1%) | 12053 / 168050 (7.2%) | −177.3 | −174.9 | 0.30 |
| GATA3 SRX176864 | MCF-7 Breast | 239 / 16805 (1.4%) | 9950 / 168050 (5.9%) | −176.9 | −174.4 | 0.24 |
| FOXA1 SRX371480 | MCF-7 Breast | 219 / 16805 (1.3%) | 9561 / 168050 (5.7%) | −176.3 | −173.8 | 0.23 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 223 / 16805 (1.3%) | 9631 / 168050 (5.7%) | −176.1 | −173.6 | 0.23 |
| ESR1 SRX10365532 | MCF-7 Breast | 158 / 16805 (0.9%) | 8368 / 168050 (5.0%) | −176.0 | −173.6 | 0.19 |
| ESR1 SRX4367192 | MCF-7 Breast | 706 / 16805 (4.2%) | 17417 / 168050 (10.4%) | −175.6 | −173.2 | 0.41 |
| FOXA1 SRX100454 | T-47D Breast | 445 / 16805 (2.6%) | 13413 / 168050 (8.0%) | −175.3 | −172.8 | 0.33 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 457 / 16805 (2.7%) | 677 / 168050 (0.4%) | −175.2 | −172.8 | 6.75 |
| ESR1 SRX2881002 | MCF-7 Breast | 305 / 16805 (1.8%) | 11050 / 168050 (6.6%) | −174.4 | −172.0 | 0.28 |
| KAT6A SRX20971022 | Fibroblasts Others | 244 / 16805 (1.5%) | 92 / 168050 (0.1%) | −174.2 | −171.8 | 26.52 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 771 / 16805 (4.6%) | 18311 / 168050 (10.9%) | −174.2 | −171.8 | 0.42 |
| RAC1 SRX10365543 | MCF-7 Breast | 163 / 16805 (1.0%) | 8411 / 168050 (5.0%) | −174.0 | −171.6 | 0.19 |
| BRPF3 SRX796084 | RKO Digestive tract | 1454 / 16805 (8.7%) | 6074 / 168050 (3.6%) | −171.7 | −169.3 | 2.39 |
| TLE3 SRX4815192 | MCF-7 Breast | 302 / 16805 (1.8%) | 10880 / 168050 (6.5%) | −170.6 | −168.2 | 0.28 |
| ESR1 SRX3110725 | MCF-7 Breast | 291 / 16805 (1.7%) | 10669 / 168050 (6.3%) | −170.0 | −167.6 | 0.27 |
| ESR1 SRX20282946 | MCF-7 Breast | 185 / 16805 (1.1%) | 8698 / 168050 (5.2%) | −169.0 | −166.6 | 0.21 |
| ESR1 SRX5323873 | MCF-7 Breast | 420 / 16805 (2.5%) | 12789 / 168050 (7.6%) | −168.7 | −166.3 | 0.33 |
| ESR1 SRX20282953 | MCF-7 Breast | 267 / 16805 (1.6%) | 10194 / 168050 (6.1%) | −168.4 | −166.0 | 0.26 |
| BRPF3 SRX796085 | RKO Digestive tract | 1034 / 16805 (6.2%) | 3551 / 168050 (2.1%) | −168.1 | −165.7 | 2.91 |
| STAT5B SRX831881 | CD8+ T cells Blood | 260 / 16805 (1.5%) | 136 / 168050 (0.1%) | −167.8 | −165.4 | 19.12 |
| ARID1A SRX5089376 | MCF-7 Breast | 298 / 16805 (1.8%) | 10716 / 168050 (6.4%) | −167.7 | −165.3 | 0.28 |
| RAC1 SRX10365541 | MCF-7 Breast | 172 / 16805 (1.0%) | 8407 / 168050 (5.0%) | −167.7 | −165.3 | 0.20 |
| FOXA1 SRX1787653 | MCF-7 Breast | 283 / 16805 (1.7%) | 10447 / 168050 (6.2%) | −167.5 | −165.1 | 0.27 |
| BRPF3 SRX796086 | RKO Digestive tract | 1396 / 16805 (8.3%) | 5785 / 168050 (3.4%) | −167.0 | −164.6 | 2.41 |
| FOS SRX150477 | MCF 10A Breast | 879 / 16805 (5.2%) | 19543 / 168050 (11.6%) | −166.5 | −164.1 | 0.45 |
| FOXA1 SRX3923514 | MCF-7 Breast | 359 / 16805 (2.1%) | 11706 / 168050 (7.0%) | −166.2 | −163.8 | 0.31 |
| ESR1 SRX330069 | MCF-7 Breast | 194 / 16805 (1.2%) | 8779 / 168050 (5.2%) | −165.8 | −163.4 | 0.22 |
| FOXA1 SRX11222437 | MCF-7 Breast | 242 / 16805 (1.4%) | 9663 / 168050 (5.8%) | −165.7 | −163.3 | 0.25 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 590 / 16805 (3.5%) | 15306 / 168050 (9.1%) | −165.1 | −162.7 | 0.39 |
| AR SRX9109110 | MDA-MB-453 Breast | 676 / 16805 (4.0%) | 16571 / 168050 (9.9%) | −164.7 | −162.4 | 0.41 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 268 / 16805 (1.6%) | 10093 / 168050 (6.0%) | −164.5 | −162.2 | 0.27 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 459 / 16805 (2.7%) | 748 / 168050 (0.4%) | −164.1 | −161.7 | 6.14 |
| NR2F2 SRX190293 | MCF-7 Breast | 373 / 16805 (2.2%) | 11860 / 168050 (7.1%) | −163.9 | −161.6 | 0.31 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 549 / 16805 (3.3%) | 1118 / 168050 (0.7%) | −163.1 | −160.7 | 4.91 |
| FOXA1 SRX3931043 | MCF-7 Breast | 360 / 16805 (2.1%) | 11616 / 168050 (6.9%) | −163.0 | −160.7 | 0.31 |
| ESR1 SRX2943591 | MCF-7 Breast | 237 / 16805 (1.4%) | 9489 / 168050 (5.6%) | −163.0 | −160.7 | 0.25 |
| FOXA1 SRX11222441 | MCF-7 Breast | 267 / 16805 (1.6%) | 10017 / 168050 (6.0%) | −162.7 | −160.3 | 0.27 |
| ESR1 SRX20282971 | MCF-7 Breast | 343 / 16805 (2.0%) | 11317 / 168050 (6.7%) | −162.6 | −160.3 | 0.30 |
| ESR1 SRX1012629 | MCF-7 Breast | 205 / 16805 (1.2%) | 8844 / 168050 (5.3%) | −161.1 | −158.8 | 0.23 |
| ESR1 SRX371475 | BT-474 Breast | 169 / 16805 (1.0%) | 8140 / 168050 (4.8%) | −160.5 | −158.2 | 0.21 |
| FOXA1 SRX3931055 | MCF-7 Breast | 297 / 16805 (1.8%) | 10461 / 168050 (6.2%) | −160.2 | −157.8 | 0.28 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 337 / 16805 (2.0%) | 11134 / 168050 (6.6%) | −160.1 | −157.7 | 0.30 |
| ESR1 SRX371477 | MCF-7 Breast | 168 / 16805 (1.0%) | 8098 / 168050 (4.8%) | −159.9 | −157.6 | 0.21 |
| ESR1 SRX371474 | BT-474 Breast | 153 / 16805 (0.9%) | 7776 / 168050 (4.6%) | −158.9 | −156.6 | 0.20 |
| SSRP1 SRX3436567 | HT-1080 Bone | 398 / 16805 (2.4%) | 557 / 168050 (0.3%) | −158.7 | −156.4 | 7.15 |
| FOXA1 SRX3931054 | MCF-7 Breast | 339 / 16805 (2.0%) | 11110 / 168050 (6.6%) | −158.3 | −156.0 | 0.31 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 396 / 16805 (2.4%) | 12045 / 168050 (7.2%) | −158.3 | −156.0 | 0.33 |
| AGO2 SRX6783957 | Hep G2 Liver | 1173 / 16805 (7.0%) | 4534 / 168050 (2.7%) | −158.1 | −155.8 | 2.59 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 334 / 16805 (2.0%) | 11010 / 168050 (6.6%) | −157.7 | −155.4 | 0.30 |
| FOS SRX150478 | MCF 10A Breast | 943 / 16805 (5.6%) | 20054 / 168050 (11.9%) | −157.2 | −154.8 | 0.47 |
| ING5 SRX286202 | RKO Digestive tract | 1269 / 16805 (7.6%) | 5155 / 168050 (3.1%) | −157.0 | −154.7 | 2.46 |
| FOXA1 SRX3923517 | MCF-7 Breast | 246 / 16805 (1.5%) | 9463 / 168050 (5.6%) | −156.8 | −154.5 | 0.26 |
| ESR1 SRX1469949 | MCF-7 Breast | 187 / 16805 (1.1%) | 8375 / 168050 (5.0%) | −156.8 | −154.5 | 0.22 |
| ESR1 SRX330070 | MCF-7 Breast | 169 / 16805 (1.0%) | 8021 / 168050 (4.8%) | −156.5 | −154.2 | 0.21 |
| FOXA1 SRX028634 | MCF-7 Breast | 166 / 16805 (1.0%) | 7963 / 168050 (4.7%) | −156.5 | −154.2 | 0.21 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 159 / 16805 (0.9%) | 7824 / 168050 (4.7%) | −156.5 | −154.2 | 0.20 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 324 / 16805 (1.9%) | 10778 / 168050 (6.4%) | −155.9 | −153.6 | 0.30 |
| ESR1 SRX3123829 | MCF-7 Breast | 194 / 16805 (1.2%) | 8476 / 168050 (5.0%) | −155.8 | −153.5 | 0.23 |
| ESR1 SRX330067 | MCF-7 Breast | 324 / 16805 (1.9%) | 10772 / 168050 (6.4%) | −155.7 | −153.4 | 0.30 |
| ESR1 SRX20282938 | MCF-7 Breast | 282 / 16805 (1.7%) | 10044 / 168050 (6.0%) | −155.3 | −153.0 | 0.28 |
| NFYB SRX16608147 | HeLa Uterus | 265 / 16805 (1.6%) | 181 / 168050 (0.1%) | −154.8 | −152.5 | 14.64 |
| AGO2 SRX6783958 | Hep G2 Liver | 1151 / 16805 (6.8%) | 4454 / 168050 (2.7%) | −154.6 | −152.3 | 2.58 |
| FOXA1 SRX3923516 | MCF-7 Breast | 256 / 16805 (1.5%) | 9567 / 168050 (5.7%) | −154.6 | −152.3 | 0.27 |
| FOXA1 SRX11222438 | MCF-7 Breast | 185 / 16805 (1.1%) | 8267 / 168050 (4.9%) | −154.4 | −152.1 | 0.22 |
| ESR1 SRX10365558 | MCF-7 Breast | 236 / 16805 (1.4%) | 9202 / 168050 (5.5%) | −154.3 | −152.1 | 0.26 |
| ARID5B SRX3230377 | Hep G2 Liver | 944 / 16805 (5.6%) | 19933 / 168050 (11.9%) | −153.9 | −151.6 | 0.47 |
| ESR1 SRX5323871 | MCF-7 Breast | 395 / 16805 (2.4%) | 11871 / 168050 (7.1%) | −153.6 | −151.3 | 0.33 |
| ESR1 SRX8537722 | MCF-7 Breast | 341 / 16805 (2.0%) | 10935 / 168050 (6.5%) | −152.1 | −149.8 | 0.31 |
| AR SRX9469988 | LAPC-4 Prostate | 504 / 16805 (3.0%) | 13517 / 168050 (8.0%) | −151.8 | −149.5 | 0.37 |
| FOXA1 SRX028635 | MCF-7 Breast | 174 / 16805 (1.0%) | 7972 / 168050 (4.7%) | −151.6 | −149.4 | 0.22 |
| FOXA1 SRX5323843 | MCF-7 Breast | 178 / 16805 (1.1%) | 8038 / 168050 (4.8%) | −151.2 | −149.0 | 0.22 |
| AR SRX9109113 | MDA-MB-453 Breast | 718 / 16805 (4.3%) | 16665 / 168050 (9.9%) | −151.2 | −149.0 | 0.43 |
| GATA3 SRX6712581 | MCF-7 Breast | 304 / 16805 (1.8%) | 10287 / 168050 (6.1%) | −151.2 | −148.9 | 0.30 |
| CDK9 SRX7366783 | MCF-7 Breast | 241 / 16805 (1.4%) | 138 / 168050 (0.1%) | −150.7 | −148.5 | 17.46 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 296 / 16805 (1.8%) | 10131 / 168050 (6.0%) | −150.6 | −148.4 | 0.29 |
| CDK9 SRX7366781 | MCF-7 Breast | 237 / 16805 (1.4%) | 130 / 168050 (0.1%) | −150.5 | −148.3 | 18.23 |
| FOXA2 SRX3230382 | Hep G2 Liver | 528 / 16805 (3.1%) | 13833 / 168050 (8.2%) | −150.5 | −148.2 | 0.38 |
| ESR1 SRX1012632 | MCF-7 Breast | 171 / 16805 (1.0%) | 7876 / 168050 (4.7%) | −150.4 | −148.1 | 0.22 |
| ESR1 SRX20282959 | MCF-7 Breast | 137 / 16805 (0.8%) | 7208 / 168050 (4.3%) | −150.3 | −148.1 | 0.19 |
| ARID1A SRX5089379 | MCF-7 Breast | 372 / 16805 (2.2%) | 11384 / 168050 (6.8%) | −150.3 | −148.0 | 0.33 |
| ESR1 SRX1012633 | MCF-7 Breast | 177 / 16805 (1.1%) | 7982 / 168050 (4.7%) | −150.1 | −147.9 | 0.22 |
| ESR1 SRX1531796 | MCF-7 Breast | 186 / 16805 (1.1%) | 8152 / 168050 (4.9%) | −150.1 | −147.9 | 0.23 |
| ESR1 SRX2912055 | MCF-7 Breast | 127 / 16805 (0.8%) | 6996 / 168050 (4.2%) | −150.1 | −147.8 | 0.18 |
| LEO1 SRX1873456 | SEM Blood | 1390 / 16805 (8.3%) | 6074 / 168050 (3.6%) | −149.8 | −147.6 | 2.29 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1081 / 16805 (6.4%) | 4105 / 168050 (2.4%) | −149.7 | −147.5 | 2.63 |
| FOXA1 SRX1787651 | MCF-7 Breast | 204 / 16805 (1.2%) | 8469 / 168050 (5.0%) | −149.4 | −147.2 | 0.24 |
| ESR1 SRX5323878 | MCF-7 Breast | 370 / 16805 (2.2%) | 11305 / 168050 (6.7%) | −148.9 | −146.7 | 0.33 |
| FOXA1 SRX5203303 | MCF-7 Breast | 112 / 16805 (0.7%) | 6650 / 168050 (4.0%) | −148.9 | −146.7 | 0.17 |
| FOXA1 SRX11222442 | MCF-7 Breast | 246 / 16805 (1.5%) | 9209 / 168050 (5.5%) | −148.8 | −146.6 | 0.27 |
| ESR1 SRX5323877 | MCF-7 Breast | 284 / 16805 (1.7%) | 9863 / 168050 (5.9%) | −148.6 | −146.4 | 0.29 |
| AR SRX1067071 | LHSAR Prostate | 768 / 16805 (4.6%) | 17267 / 168050 (10.3%) | −148.6 | −146.3 | 0.44 |
| ESR1 SRX11120903 | MCF-7 Breast | 316 / 16805 (1.9%) | 10402 / 168050 (6.2%) | −148.4 | −146.2 | 0.30 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 350 / 16805 (2.1%) | 10954 / 168050 (6.5%) | −148.1 | −145.9 | 0.32 |
| FOXA1 SRX1787655 | MCF-7 Breast | 180 / 16805 (1.1%) | 7971 / 168050 (4.7%) | −147.7 | −145.5 | 0.23 |
| TP53 SRX19538272 | U2OS Bone | 536 / 16805 (3.2%) | 1183 / 168050 (0.7%) | −147.5 | −145.3 | 4.53 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 939 / 16805 (5.6%) | 19590 / 168050 (11.7%) | −147.3 | −145.1 | 0.48 |
| EP300 SRX176885 | MCF-7 Breast | 189 / 16805 (1.1%) | 8123 / 168050 (4.8%) | −147.1 | −144.9 | 0.23 |
| PGR SRX1012655 | MCF-7 Breast | 234 / 16805 (1.4%) | 8939 / 168050 (5.3%) | −147.1 | −144.9 | 0.26 |
| FOXA1 SRX3923519 | MCF-7 Breast | 225 / 16805 (1.3%) | 8777 / 168050 (5.2%) | −147.0 | −144.8 | 0.26 |
| ESR1 SRX5323872 | MCF-7 Breast | 374 / 16805 (2.2%) | 11306 / 168050 (6.7%) | −146.9 | −144.8 | 0.33 |
| EP300 SRX1012648 | MCF-7 Breast | 170 / 16805 (1.0%) | 7738 / 168050 (4.6%) | −146.3 | −144.2 | 0.22 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1357 / 16805 (8.1%) | 25055 / 168050 (14.9%) | −145.9 | −143.7 | 0.54 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 915 / 16805 (5.4%) | 19199 / 168050 (11.4%) | −145.8 | −143.6 | 0.48 |
| ESR1 SRX10365533 | MCF-7 Breast | 172 / 16805 (1.0%) | 7756 / 168050 (4.6%) | −145.7 | −143.5 | 0.22 |
| FOXA1 SRX100506 | Hep G2 Liver | 524 / 16805 (3.1%) | 13595 / 168050 (8.1%) | −145.6 | −143.4 | 0.39 |
| FOXA1 SRX1787652 | MCF-7 Breast | 227 / 16805 (1.4%) | 8762 / 168050 (5.2%) | −145.4 | −143.3 | 0.26 |
| ESR1 SRX3110723 | MCF-7 Breast | 194 / 16805 (1.2%) | 8160 / 168050 (4.9%) | −145.4 | −143.2 | 0.24 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 561 / 16805 (3.3%) | 14146 / 168050 (8.4%) | −145.4 | −143.2 | 0.40 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 324 / 16805 (1.9%) | 10430 / 168050 (6.2%) | −145.3 | −143.1 | 0.31 |
| ESR1 SRX4451213 | MCF-7 Breast | 390 / 16805 (2.3%) | 11470 / 168050 (6.8%) | −144.4 | −142.2 | 0.34 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 847 / 16805 (5.0%) | 2811 / 168050 (1.7%) | −144.2 | −142.1 | 3.01 |
| FOXA1 SRX3923518 | MCF-7 Breast | 260 / 16805 (1.5%) | 9305 / 168050 (5.5%) | −144.1 | −141.9 | 0.28 |
| FOXA1 SRX3931033 | MCF-7 Breast | 238 / 16805 (1.4%) | 8915 / 168050 (5.3%) | −143.9 | −141.8 | 0.27 |
| ESR1 SRX2943589 | MCF-7 Breast | 188 / 16805 (1.1%) | 8001 / 168050 (4.8%) | −143.8 | −141.6 | 0.23 |
| ESR1 SRX1469951 | MCF-7 Breast | 188 / 16805 (1.1%) | 7993 / 168050 (4.8%) | −143.6 | −141.5 | 0.24 |
| AR SRX1067070 | LHSAR Prostate | 959 / 16805 (5.7%) | 19695 / 168050 (11.7%) | −143.3 | −141.1 | 0.49 |
| TP53 SRX396254 | Fibroblasts Others | 828 / 16805 (4.9%) | 2718 / 168050 (1.6%) | −143.0 | −140.8 | 3.05 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 486 / 16805 (2.9%) | 1001 / 168050 (0.6%) | −142.8 | −140.6 | 4.86 |
| FOXA1 SRX5323829 | T-47D Breast | 204 / 16805 (1.2%) | 8246 / 168050 (4.9%) | −142.2 | −140.0 | 0.25 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 771 / 16805 (4.6%) | 2419 / 168050 (1.4%) | −141.9 | −139.7 | 3.19 |
| FOXA1 SRX1161203 | T-47D Breast | 274 / 16805 (1.6%) | 9473 / 168050 (5.6%) | −141.8 | −139.7 | 0.29 |
| ESR1 SRX1012625 | MCF-7 Breast | 191 / 16805 (1.1%) | 7983 / 168050 (4.8%) | −141.4 | −139.3 | 0.24 |
| ARID1A SRX5089391 | MCF-7 Breast | 217 / 16805 (1.3%) | 8434 / 168050 (5.0%) | −140.6 | −138.4 | 0.26 |
| EP300 SRX1012644 | MCF-7 Breast | 167 / 16805 (1.0%) | 7506 / 168050 (4.5%) | −140.6 | −138.4 | 0.22 |
| SSRP1 SRX3436566 | HT-1080 Bone | 309 / 16805 (1.8%) | 352 / 168050 (0.2%) | −140.3 | −138.2 | 8.78 |
| Epitope tags DRX443510 | 293 Kidney | 1365 / 16805 (8.1%) | 6106 / 168050 (3.6%) | −140.1 | −138.0 | 2.24 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 185 / 16805 (1.1%) | 7830 / 168050 (4.7%) | −140.1 | −138.0 | 0.24 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1473 / 16805 (8.8%) | 26255 / 168050 (15.6%) | −139.9 | −137.8 | 0.56 |
| ESR1 SRX8537723 | MCF-7 Breast | 312 / 16805 (1.9%) | 10045 / 168050 (6.0%) | −139.9 | −137.7 | 0.31 |
| CEBPB SRX150632 | HeLa Uterus | 905 / 16805 (5.4%) | 18779 / 168050 (11.2%) | −139.0 | −136.9 | 0.48 |
| ARID1A SRX5089385 | MCF-7 Breast | 292 / 16805 (1.7%) | 9673 / 168050 (5.8%) | −138.7 | −136.6 | 0.30 |
| FOXA1 SRX3931056 | MCF-7 Breast | 227 / 16805 (1.4%) | 8547 / 168050 (5.1%) | −138.6 | −136.4 | 0.27 |
| FOXA1 SRX1961158 | T-47D Breast | 390 / 16805 (2.3%) | 11264 / 168050 (6.7%) | −138.4 | −136.3 | 0.35 |
| ESR1 SRX2881001 | MCF-7 Breast | 208 / 16805 (1.2%) | 8199 / 168050 (4.9%) | −138.4 | −136.2 | 0.25 |
| ESR1 SRX330068 | MCF-7 Breast | 177 / 16805 (1.1%) | 7627 / 168050 (4.5%) | −138.3 | −136.2 | 0.23 |
| ESR1 SRX1012628 | MCF-7 Breast | 191 / 16805 (1.1%) | 7889 / 168050 (4.7%) | −138.3 | −136.2 | 0.24 |
| TEAD1 SRX3401272 | MCF-7 Breast | 304 / 16805 (1.8%) | 9854 / 168050 (5.9%) | −138.1 | −136.0 | 0.31 |
| ESR1 SRX2513517 | MCF-7 Breast | 259 / 16805 (1.5%) | 9085 / 168050 (5.4%) | −137.8 | −135.7 | 0.29 |
| YAP1 SRX757325 | H2052 Lung | 1018 / 16805 (6.1%) | 20234 / 168050 (12.0%) | −137.4 | −135.3 | 0.50 |
| FOXA2 SRX100448 | Hep G2 Liver | 453 / 16805 (2.7%) | 12203 / 168050 (7.3%) | −137.2 | −135.1 | 0.37 |
| ETS1 SRX3033231 | HEYA8 Gonad | 289 / 16805 (1.7%) | 305 / 168050 (0.2%) | −137.1 | −135.0 | 9.48 |
| FOXA1 SRX3923515 | MCF-7 Breast | 216 / 16805 (1.3%) | 8301 / 168050 (4.9%) | −137.0 | −134.9 | 0.26 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 260 / 16805 (1.5%) | 9066 / 168050 (5.4%) | −136.8 | −134.7 | 0.29 |
| ESR1 SRX5323874 | MCF-7 Breast | 226 / 16805 (1.3%) | 8473 / 168050 (5.0%) | −136.7 | −134.6 | 0.27 |
| ESR1 SRX4451212 | MCF-7 Breast | 377 / 16805 (2.2%) | 10995 / 168050 (6.5%) | −136.6 | −134.5 | 0.34 |
| ESR1 SRX1012630 | MCF-7 Breast | 143 / 16805 (0.9%) | 6924 / 168050 (4.1%) | −136.5 | −134.4 | 0.21 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 217 / 16805 (1.3%) | 123 / 168050 (0.1%) | −136.3 | −134.2 | 17.64 |
| FOXA1 SRX3931032 | MCF-7 Breast | 226 / 16805 (1.3%) | 8452 / 168050 (5.0%) | −136.2 | −134.1 | 0.27 |
| SOX13 SRX2636248 | Hep G2 Liver | 561 / 16805 (3.3%) | 13794 / 168050 (8.2%) | −136.1 | −134.0 | 0.41 |
| FOXA1 SRX1447317 | MCF-7 Breast | 259 / 16805 (1.5%) | 9023 / 168050 (5.4%) | −136.0 | −133.9 | 0.29 |
| ESR1 SRX2513520 | MCF-7 Breast | 244 / 16805 (1.5%) | 8740 / 168050 (5.2%) | −135.3 | −133.2 | 0.28 |
| ARID1A SRX5089382 | MCF-7 Breast | 279 / 16805 (1.7%) | 9336 / 168050 (5.6%) | −135.1 | −133.0 | 0.30 |
| FOXA1 SRX15430999 | T-47D Breast | 446 / 16805 (2.7%) | 12020 / 168050 (7.2%) | −135.1 | −133.0 | 0.37 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 531 / 16805 (3.2%) | 13300 / 168050 (7.9%) | −134.8 | −132.7 | 0.40 |
| JUNB SRX8488088 | SUM 229PE Breast | 805 / 16805 (4.8%) | 17188 / 168050 (10.2%) | −133.9 | −131.8 | 0.47 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 719 / 16805 (4.3%) | 2240 / 168050 (1.3%) | −133.5 | −131.4 | 3.21 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1388 / 16805 (8.3%) | 24858 / 168050 (14.8%) | −133.3 | −131.3 | 0.56 |
| ESR1 SRX10365534 | MCF-7 Breast | 113 / 16805 (0.7%) | 6220 / 168050 (3.7%) | −133.2 | −131.1 | 0.18 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 139 / 16805 (0.8%) | 6733 / 168050 (4.0%) | −132.8 | −130.7 | 0.21 |
| FOXA1 SRX5203307 | MCF-7 Breast | 113 / 16805 (0.7%) | 6208 / 168050 (3.7%) | −132.7 | −130.6 | 0.18 |
| ESR1 SRX2513521 | MCF-7 Breast | 187 / 16805 (1.1%) | 7641 / 168050 (4.5%) | −132.7 | −130.6 | 0.24 |
| ESR1 SRX3110720 | MCF-7 Breast | 158 / 16805 (0.9%) | 7095 / 168050 (4.2%) | −132.6 | −130.5 | 0.22 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 693 / 16805 (4.1%) | 2110 / 168050 (1.3%) | −132.6 | −130.5 | 3.28 |
| FOXA1 SRX5323846 | MCF-7 Breast | 143 / 16805 (0.9%) | 6806 / 168050 (4.0%) | −132.5 | −130.4 | 0.21 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 228 / 16805 (1.4%) | 8371 / 168050 (5.0%) | −132.4 | −130.4 | 0.27 |
| FOXA1 SRX1961157 | T-47D Breast | 444 / 16805 (2.6%) | 11893 / 168050 (7.1%) | −132.4 | −130.4 | 0.37 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 275 / 16805 (1.6%) | 9176 / 168050 (5.5%) | −132.3 | −130.2 | 0.30 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 271 / 16805 (1.6%) | 9101 / 168050 (5.4%) | −132.2 | −130.1 | 0.30 |
| ESR1 SRX20282966 | MCF-7 Breast | 135 / 16805 (0.8%) | 6630 / 168050 (3.9%) | −132.0 | −129.9 | 0.20 |
| GATAD2A SRX2636506 | Hep G2 Liver | 531 / 16805 (3.2%) | 13187 / 168050 (7.8%) | −131.9 | −129.9 | 0.40 |
| FOS SRX4192880 | MCF 10A Breast | 722 / 16805 (4.3%) | 15937 / 168050 (9.5%) | −131.7 | −129.7 | 0.45 |
| MEAF6 DRX234811 | 293 Kidney | 1537 / 16805 (9.1%) | 7479 / 168050 (4.5%) | −131.5 | −129.4 | 2.06 |
| FOXA1 SRX100477 | Hep G2 Liver | 477 / 16805 (2.8%) | 12349 / 168050 (7.3%) | −131.1 | −129.0 | 0.39 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 354 / 16805 (2.1%) | 10428 / 168050 (6.2%) | −131.0 | −128.9 | 0.34 |
| ESR1 SRX5534831 | MCF-7 Breast | 310 / 16805 (1.8%) | 9714 / 168050 (5.8%) | −130.9 | −128.8 | 0.32 |
| FOXA1 SRX1787654 | MCF-7 Breast | 146 / 16805 (0.9%) | 6815 / 168050 (4.1%) | −130.8 | −128.8 | 0.21 |
| ESR1 SRX1995229 | MCF-7 Breast | 402 / 16805 (2.4%) | 11177 / 168050 (6.7%) | −130.7 | −128.6 | 0.36 |
| FOXA2 SRX10475773 | Hep G2 Liver | 503 / 16805 (3.0%) | 12726 / 168050 (7.6%) | −130.7 | −128.6 | 0.40 |
| ESR1 SRX1012631 | MCF-7 Breast | 172 / 16805 (1.0%) | 7299 / 168050 (4.3%) | −130.5 | −128.5 | 0.24 |
| MEAF6 DRX300417 | 293 Kidney | 1410 / 16805 (8.4%) | 6621 / 168050 (3.9%) | −130.4 | −128.3 | 2.13 |
| FOXA1 SRX5323830 | T-47D Breast | 237 / 16805 (1.4%) | 8459 / 168050 (5.0%) | −130.3 | −128.3 | 0.28 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 358 / 16805 (2.1%) | 10467 / 168050 (6.2%) | −130.3 | −128.2 | 0.34 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 530 / 16805 (3.2%) | 13111 / 168050 (7.8%) | −130.3 | −128.2 | 0.40 |
| FOS SRX150517 | MCF 10A Breast | 724 / 16805 (4.3%) | 15900 / 168050 (9.5%) | −130.1 | −128.1 | 0.46 |
| TFAP2C SRX018833 | MCF-7 Breast | 377 / 16805 (2.2%) | 10748 / 168050 (6.4%) | −129.7 | −127.6 | 0.35 |
| EP300 SRX176883 | MCF-7 Breast | 189 / 16805 (1.1%) | 7582 / 168050 (4.5%) | −129.6 | −127.5 | 0.25 |
| TFAP2C SRX128099 | MCF-7 Breast | 377 / 16805 (2.2%) | 10736 / 168050 (6.4%) | −129.2 | −127.2 | 0.35 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 807 / 16805 (4.8%) | 17019 / 168050 (10.1%) | −129.2 | −127.2 | 0.47 |
| ARID5B SRX10475138 | Hep G2 Liver | 688 / 16805 (4.1%) | 15353 / 168050 (9.1%) | −129.2 | −127.1 | 0.45 |
| FOXA1 SRX6878603 | LNCAP Prostate | 456 / 16805 (2.7%) | 11952 / 168050 (7.1%) | −129.1 | −127.0 | 0.38 |
| EP300 SRX1012643 | MCF-7 Breast | 146 / 16805 (0.9%) | 6758 / 168050 (4.0%) | −129.0 | −127.0 | 0.22 |
| ESR1 SRX5323876 | MCF-7 Breast | 213 / 16805 (1.3%) | 7997 / 168050 (4.8%) | −129.0 | −127.0 | 0.27 |
| ARID1A SRX5089388 | MCF-7 Breast | 211 / 16805 (1.3%) | 7957 / 168050 (4.7%) | −129.0 | −127.0 | 0.27 |
| YAP1 SRX757326 | H2052 Lung | 884 / 16805 (5.3%) | 18060 / 168050 (10.7%) | −128.9 | −126.9 | 0.49 |
| FOXA1 SRX5323845 | MCF-7 Breast | 146 / 16805 (0.9%) | 6754 / 168050 (4.0%) | −128.9 | −126.9 | 0.22 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 424 / 16805 (2.5%) | 11453 / 168050 (6.8%) | −128.8 | −126.8 | 0.37 |
| FOXA1 SRX5203294 | MCF-7 Breast | 115 / 16805 (0.7%) | 6129 / 168050 (3.6%) | −128.5 | −126.5 | 0.19 |
| NR3C1 SRX19024866 | MCF-7 Breast | 144 / 16805 (0.9%) | 6702 / 168050 (4.0%) | −128.5 | −126.5 | 0.21 |
| NANOG SRX10445309 | Neural crest cells Neural | 227 / 16805 (1.4%) | 8226 / 168050 (4.9%) | −128.5 | −126.4 | 0.28 |
| ESR1 SRX1469950 | MCF-7 Breast | 144 / 16805 (0.9%) | 6701 / 168050 (4.0%) | −128.3 | −126.3 | 0.21 |
| FOXA1 SRX3923511 | MCF-7 Breast | 154 / 16805 (0.9%) | 6870 / 168050 (4.1%) | −127.7 | −125.7 | 0.22 |
| NR3C1 SRX19024870 | MCF-7 Breast | 138 / 16805 (0.8%) | 6555 / 168050 (3.9%) | −127.4 | −125.4 | 0.21 |
| ESR1 SRX1995230 | MCF-7 Breast | 346 / 16805 (2.1%) | 10173 / 168050 (6.1%) | −127.3 | −125.3 | 0.34 |
| HMG20A SRX2630163 | Hep G2 Liver | 240 / 16805 (1.4%) | 8405 / 168050 (5.0%) | −127.1 | −125.0 | 0.29 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 565 / 16805 (3.4%) | 13474 / 168050 (8.0%) | −126.3 | −124.3 | 0.42 |
| FOXA1 SRX3931031 | MCF-7 Breast | 195 / 16805 (1.2%) | 7587 / 168050 (4.5%) | −126.3 | −124.3 | 0.26 |
| ESR1 SRX9719167 | MCF-7 Breast | 181 / 16805 (1.1%) | 7330 / 168050 (4.4%) | −126.2 | −124.1 | 0.25 |
| ESR1 SRX3123823 | MCF-7 Breast | 139 / 16805 (0.8%) | 6536 / 168050 (3.9%) | −126.1 | −124.1 | 0.21 |
| TET2 SRX8617001 | MCF-7 Breast | 273 / 16805 (1.6%) | 8928 / 168050 (5.3%) | −126.0 | −123.9 | 0.31 |
| 5-mC SRX882970 | LNCAP Prostate | 2534 / 16805 (15.1%) | 15146 / 168050 (9.0%) | −125.6 | −123.6 | 1.67 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 734 / 16805 (4.4%) | 15854 / 168050 (9.4%) | −125.5 | −123.5 | 0.46 |
| ESR1 SRX2513519 | MCF-7 Breast | 225 / 16805 (1.3%) | 8091 / 168050 (4.8%) | −125.4 | −123.4 | 0.28 |
| FOXA1 SRX1161205 | T-47D Breast | 222 / 16805 (1.3%) | 8037 / 168050 (4.8%) | −125.4 | −123.4 | 0.28 |
| GATA3 SRX5457550 | MCF-7 Breast | 479 / 16805 (2.9%) | 12159 / 168050 (7.2%) | −125.3 | −123.3 | 0.39 |
| ZEB1 SRX13298925 | MCF-7 Breast | 264 / 16805 (1.6%) | 8749 / 168050 (5.2%) | −125.1 | −123.1 | 0.30 |
| RAD21 SRX3482875 | hESC HUES64 Pluripotent stem cell | 658 / 16805 (3.9%) | 14756 / 168050 (8.8%) | −124.9 | −122.9 | 0.45 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 311 / 16805 (1.9%) | 9506 / 168050 (5.7%) | −124.5 | −122.5 | 0.33 |
| GATAD2A SRX2636507 | Hep G2 Liver | 464 / 16805 (2.8%) | 11897 / 168050 (7.1%) | −124.3 | −122.3 | 0.39 |
| ARID5B SRX10475139 | Hep G2 Liver | 469 / 16805 (2.8%) | 11972 / 168050 (7.1%) | −124.2 | −122.2 | 0.39 |
| ESR1 SRX4451214 | MCF-7 Breast | 367 / 16805 (2.2%) | 10387 / 168050 (6.2%) | −124.0 | −122.0 | 0.35 |
| ESR1 SRX792933 | LY2 Breast | 348 / 16805 (2.1%) | 10076 / 168050 (6.0%) | −123.7 | −121.7 | 0.35 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 182 / 16805 (1.1%) | 82 / 168050 (0.0%) | −123.5 | −121.5 | 22.20 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 410 / 16805 (2.4%) | 11035 / 168050 (6.6%) | −123.3 | −121.3 | 0.37 |
| ESR1 SRX2513518 | MCF-7 Breast | 206 / 16805 (1.2%) | 7685 / 168050 (4.6%) | −123.2 | −121.2 | 0.27 |
| FOXA1 SRX1447316 | MCF-7 Breast | 182 / 16805 (1.1%) | 7252 / 168050 (4.3%) | −123.2 | −121.2 | 0.25 |
| MAU2 SRX11120892 | MCF-7 Breast | 177 / 16805 (1.1%) | 7157 / 168050 (4.3%) | −123.1 | −121.1 | 0.25 |
| PROX1 SRX3230397 | Hep G2 Liver | 318 / 16805 (1.9%) | 9571 / 168050 (5.7%) | −123.0 | −121.0 | 0.33 |
| ESR1 SRX3123830 | MCF-7 Breast | 113 / 16805 (0.7%) | 5916 / 168050 (3.5%) | −122.6 | −120.6 | 0.19 |
| ESR1 SRX5534832 | MCF-7 Breast | 391 / 16805 (2.3%) | 10715 / 168050 (6.4%) | −122.5 | −120.5 | 0.36 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 188 / 16805 (1.1%) | 96 / 168050 (0.1%) | −122.5 | −120.5 | 19.58 |
| ESR1 SRX3554403 | MDA-MB-134-VI Breast | 187 / 16805 (1.1%) | 7318 / 168050 (4.4%) | −122.2 | −120.3 | 0.26 |
| ESR1 SRX176856 | MCF-7 Breast | 142 / 16805 (0.8%) | 6477 / 168050 (3.9%) | −122.2 | −120.2 | 0.22 |
| CEBPA SRX2630241 | Hep G2 Liver | 530 / 16805 (3.2%) | 12785 / 168050 (7.6%) | −121.8 | −119.8 | 0.41 |
| MLLT6 DRX059637 | 293 Kidney | 364 / 16805 (2.2%) | 645 / 168050 (0.4%) | −121.8 | −119.8 | 5.64 |
| GFP SRX6949256 | HeLa Uterus | 470 / 16805 (2.8%) | 11891 / 168050 (7.1%) | −121.7 | −119.7 | 0.40 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 270 / 16805 (1.6%) | 8729 / 168050 (5.2%) | −121.5 | −119.5 | 0.31 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 506 / 16805 (3.0%) | 12417 / 168050 (7.4%) | −121.4 | −119.5 | 0.41 |
| AR SRX15946405 | MDA-MB-453 Breast | 277 / 16805 (1.6%) | 8841 / 168050 (5.3%) | −121.3 | −119.3 | 0.31 |
| ESR1 SRX5089450 | MCF-7 Breast | 230 / 16805 (1.4%) | 8020 / 168050 (4.8%) | −120.5 | −118.5 | 0.29 |
| ESR1 SRX5089447 | MCF-7 Breast | 197 / 16805 (1.2%) | 7427 / 168050 (4.4%) | −120.1 | −118.1 | 0.27 |
| AR SRX11149848 | MDA-MB-453 Breast | 280 / 16805 (1.7%) | 8847 / 168050 (5.3%) | −120.0 | −118.0 | 0.32 |
| FOXA1 SRX3923510 | MCF-7 Breast | 163 / 16805 (1.0%) | 6803 / 168050 (4.0%) | −120.0 | −118.0 | 0.24 |
| ESR1 SRX5323875 | MCF-7 Breast | 156 / 16805 (0.9%) | 6668 / 168050 (4.0%) | −119.8 | −117.8 | 0.23 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 811 / 16805 (4.8%) | 16660 / 168050 (9.9%) | −119.6 | −117.6 | 0.49 |
| NCOA3 SRX4663589 | MCF-7 Breast | 123 / 16805 (0.7%) | 6024 / 168050 (3.6%) | −119.4 | −117.5 | 0.20 |
| STAT3 SRX2020842 | HCC70 Breast | 754 / 16805 (4.5%) | 15867 / 168050 (9.4%) | −119.4 | −117.4 | 0.48 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 225 / 16805 (1.3%) | 7875 / 168050 (4.7%) | −118.7 | −116.8 | 0.29 |
| KMT2C SRX1787675 | MCF-7 Breast | 387 / 16805 (2.3%) | 10499 / 168050 (6.2%) | −118.4 | −116.4 | 0.37 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 428 / 16805 (2.5%) | 11126 / 168050 (6.6%) | −118.3 | −116.3 | 0.38 |
| FOXA1 SRX3923509 | MCF-7 Breast | 124 / 16805 (0.7%) | 6004 / 168050 (3.6%) | −118.1 | −116.1 | 0.21 |
| ESR1 SRX968963 | MCF-7 Breast | 175 / 16805 (1.0%) | 6964 / 168050 (4.1%) | −117.9 | −115.9 | 0.25 |
| Epitope tags SRX10549778 | K-562 Blood | 993 / 16805 (5.9%) | 4108 / 168050 (2.4%) | −117.7 | −115.8 | 2.42 |
| NR3C1 SRX19024880 | MCF-7 Breast | 114 / 16805 (0.7%) | 5794 / 168050 (3.4%) | −117.7 | −115.7 | 0.20 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 456 / 16805 (2.7%) | 11521 / 168050 (6.9%) | −117.5 | −115.5 | 0.40 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 125 / 16805 (0.7%) | 6000 / 168050 (3.6%) | −117.4 | −115.4 | 0.21 |
| STAT3 SRX5323860 | MCF-7 Breast | 544 / 16805 (3.2%) | 12816 / 168050 (7.6%) | −117.4 | −115.4 | 0.42 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 432 / 16805 (2.6%) | 11148 / 168050 (6.6%) | −117.3 | −115.4 | 0.39 |
| SOX5 SRX2636544 | Hep G2 Liver | 446 / 16805 (2.7%) | 11356 / 168050 (6.8%) | −117.1 | −115.1 | 0.39 |
| FOXA1 SRX8537736 | MCF-7 Breast | 156 / 16805 (0.9%) | 6584 / 168050 (3.9%) | −117.1 | −115.1 | 0.24 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 143 / 16805 (0.9%) | 6339 / 168050 (3.8%) | −117.0 | −115.0 | 0.23 |
| TEAD3 SRX2636153 | Hep G2 Liver | 1028 / 16805 (6.1%) | 19433 / 168050 (11.6%) | −116.8 | −114.8 | 0.53 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 521 / 16805 (3.1%) | 1397 / 168050 (0.8%) | −116.5 | −114.5 | 3.73 |
| GATA3 SRX100559 | T-47D Breast | 488 / 16805 (2.9%) | 11948 / 168050 (7.1%) | −116.3 | −114.3 | 0.41 |
| ESR1 SRX7624162 | T-47D Breast | 252 / 16805 (1.5%) | 8250 / 168050 (4.9%) | −116.1 | −114.2 | 0.31 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 759 / 16805 (4.5%) | 15796 / 168050 (9.4%) | −116.0 | −114.1 | 0.48 |
| YAP1 SRX5718140 | 293 Kidney | 750 / 16805 (4.5%) | 15666 / 168050 (9.3%) | −115.9 | −114.0 | 0.48 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 306 / 16805 (1.8%) | 9128 / 168050 (5.4%) | −115.9 | −114.0 | 0.34 |
| FOXA2 SRX11650947 | hESC derived pancreatic cells Pluripotent stem cell | 306 / 16805 (1.8%) | 9131 / 168050 (5.4%) | −115.9 | −114.0 | 0.34 |
| FOXA1 SRX5323844 | MCF-7 Breast | 124 / 16805 (0.7%) | 5935 / 168050 (3.5%) | −115.8 | −113.9 | 0.21 |
| FOXA2 SRX11650941 | hESC derived pancreatic cells Pluripotent stem cell | 224 / 16805 (1.3%) | 7756 / 168050 (4.6%) | −115.7 | −113.8 | 0.29 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 623 / 16805 (3.7%) | 13876 / 168050 (8.3%) | −115.5 | −113.5 | 0.45 |
| KDM6A SRX15826236 | MCF-7 Breast | 146 / 16805 (0.9%) | 6344 / 168050 (3.8%) | −115.4 | −113.5 | 0.23 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 346 / 16805 (2.1%) | 9749 / 168050 (5.8%) | −115.3 | −113.4 | 0.35 |
| VGLL1 SRX18013277 | FULVR Breast | 197 / 16805 (1.2%) | 7271 / 168050 (4.3%) | −115.2 | −113.3 | 0.27 |
| ESR1 SRX371446 | Tumour tissues Others | 459 / 16805 (2.7%) | 11473 / 168050 (6.8%) | −115.2 | −113.2 | 0.40 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 408 / 16805 (2.4%) | 10700 / 168050 (6.4%) | −115.0 | −113.1 | 0.38 |
| FOXA1 SRX3931073 | MCF-7 Breast | 270 / 16805 (1.6%) | 8505 / 168050 (5.1%) | −114.9 | −112.9 | 0.32 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 189 / 16805 (1.1%) | 7112 / 168050 (4.2%) | −114.8 | −112.8 | 0.27 |
| CBX3 SRX6712570 | MCF-7 Breast | 348 / 16805 (2.1%) | 9754 / 168050 (5.8%) | −114.5 | −112.6 | 0.36 |
| TET2 SRX8617003 | MCF-7 Breast | 145 / 16805 (0.9%) | 6297 / 168050 (3.7%) | −114.4 | −112.5 | 0.23 |
| AR SRX9109109 | MDA-MB-453 Breast | 514 / 16805 (3.1%) | 12254 / 168050 (7.3%) | −114.2 | −112.3 | 0.42 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 402 / 16805 (2.4%) | 10572 / 168050 (6.3%) | −114.1 | −112.2 | 0.38 |
| CBX3 SRX055348 | HCT 116 Digestive tract | 329 / 16805 (2.0%) | 558 / 168050 (0.3%) | −114.0 | −112.1 | 5.90 |
| FOXA1 SRX3923513 | MCF-7 Breast | 140 / 16805 (0.8%) | 6189 / 168050 (3.7%) | −114.0 | −112.0 | 0.23 |
| CEBPB SRX190345 | MCF-7 Breast | 353 / 16805 (2.1%) | 9805 / 168050 (5.8%) | −113.9 | −112.0 | 0.36 |
| FOXA1 SRX1161207 | T-47D Breast | 188 / 16805 (1.1%) | 7064 / 168050 (4.2%) | −113.8 | −111.9 | 0.27 |
| ESR1 SRX20282967 | MCF-7 Breast | 137 / 16805 (0.8%) | 6122 / 168050 (3.6%) | −113.6 | −111.7 | 0.22 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 179 / 16805 (1.1%) | 6899 / 168050 (4.1%) | −113.6 | −111.7 | 0.26 |
| ESR1 SRX1585242 | MCF-7 Breast | 171 / 16805 (1.0%) | 6753 / 168050 (4.0%) | −113.5 | −111.6 | 0.25 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 430 / 16805 (2.6%) | 10970 / 168050 (6.5%) | −113.4 | −111.5 | 0.39 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 371 / 16805 (2.2%) | 10063 / 168050 (6.0%) | −113.3 | −111.4 | 0.37 |
| GFP SRX5417098 | HeLa Uterus | 521 / 16805 (3.1%) | 12308 / 168050 (7.3%) | −113.1 | −111.1 | 0.42 |
| ZEB1 SRX13298923 | MCF-7 Breast | 197 / 16805 (1.2%) | 7203 / 168050 (4.3%) | −113.0 | −111.1 | 0.27 |
| KAT7 DRX234808 | 293 Kidney | 688 / 16805 (4.1%) | 2336 / 168050 (1.4%) | −112.9 | −111.0 | 2.95 |
| ESR1 SRX3080213 | MCF-7 Breast | 118 / 16805 (0.7%) | 5729 / 168050 (3.4%) | −112.8 | −110.9 | 0.21 |
| FOXA1 SRX1161172 | MCF-7 Breast | 453 / 16805 (2.7%) | 11287 / 168050 (6.7%) | −112.6 | −110.7 | 0.40 |
| FOXA1 SRX8537737 | MCF-7 Breast | 177 / 16805 (1.1%) | 6823 / 168050 (4.1%) | −112.4 | −110.5 | 0.26 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 498 / 16805 (3.0%) | 11948 / 168050 (7.1%) | −112.4 | −110.5 | 0.42 |
| AR SRX1067066 | LHSAR Prostate | 924 / 16805 (5.5%) | 17854 / 168050 (10.6%) | −112.3 | −110.4 | 0.52 |
| RAD21 SRX2636489 | Liver Liver | 810 / 16805 (4.8%) | 16327 / 168050 (9.7%) | −112.3 | −110.4 | 0.50 |
| CHD1 SRX186771 | K-562 Blood | 635 / 16805 (3.8%) | 2048 / 168050 (1.2%) | −112.2 | −110.3 | 3.10 |
| VGLL1 SRX24602130 | BT-20 Breast | 481 / 16805 (2.9%) | 11684 / 168050 (7.0%) | −112.1 | −110.2 | 0.41 |
| 5-mC SRX882968 | LNCAP Prostate | 2468 / 16805 (14.7%) | 15112 / 168050 (9.0%) | −112.0 | −110.1 | 1.63 |
| ESR1 SRX176858 | MCF-7 Breast | 154 / 16805 (0.9%) | 6391 / 168050 (3.8%) | −111.9 | −110.0 | 0.24 |
| SP1 SRX5457499 | Liver Liver | 763 / 16805 (4.5%) | 15669 / 168050 (9.3%) | −111.9 | −110.0 | 0.49 |
| FOXA2 SRX11650943 | hESC derived pancreatic cells Pluripotent stem cell | 286 / 16805 (1.7%) | 8665 / 168050 (5.2%) | −111.9 | −110.0 | 0.33 |
| ESR1 SRX7427512 | MCF-7 Breast | 444 / 16805 (2.6%) | 11124 / 168050 (6.6%) | −111.8 | −109.9 | 0.40 |
| MAU2 SRX11120893 | MCF-7 Breast | 188 / 16805 (1.1%) | 6997 / 168050 (4.2%) | −111.7 | −109.8 | 0.27 |
| FOXA1 SRX3923508 | MCF-7 Breast | 148 / 16805 (0.9%) | 6271 / 168050 (3.7%) | −111.7 | −109.8 | 0.24 |
| FOXA1 SRX1961163 | T-47D Breast | 299 / 16805 (1.8%) | 8863 / 168050 (5.3%) | −111.6 | −109.7 | 0.34 |
| FOXA1 SRX6860635 | T-47D Breast | 347 / 16805 (2.1%) | 9627 / 168050 (5.7%) | −111.6 | −109.7 | 0.36 |
| FOXA1 SRX3923512 | MCF-7 Breast | 128 / 16805 (0.8%) | 5883 / 168050 (3.5%) | −111.5 | −109.6 | 0.22 |
| HNF4A SRX10475578 | Hep G2 Liver | 501 / 16805 (3.0%) | 11944 / 168050 (7.1%) | −111.3 | −109.4 | 0.42 |
| Epitope tags SRX1165090 | Hep G2 Liver | 527 / 16805 (3.1%) | 12309 / 168050 (7.3%) | −110.9 | −109.0 | 0.43 |
| RUNX1 SRX2513054 | 293 Kidney | 2809 / 16805 (16.7%) | 17922 / 168050 (10.7%) | −110.8 | −108.9 | 1.57 |
| AHR SRX20282969 | MCF-7 Breast | 218 / 16805 (1.3%) | 7490 / 168050 (4.5%) | −110.7 | −108.8 | 0.29 |
| EP300 SRX100544 | Hep G2 Liver | 358 / 16805 (2.1%) | 9768 / 168050 (5.8%) | −110.7 | −108.8 | 0.37 |
| ESR1 SRX5287697 | MCF-7 Breast | 169 / 16805 (1.0%) | 6622 / 168050 (3.9%) | −110.6 | −108.7 | 0.26 |
| RAD21 SRX2630139 | Hep G2 Liver | 528 / 16805 (3.1%) | 12312 / 168050 (7.3%) | −110.6 | −108.7 | 0.43 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 442 / 16805 (2.6%) | 11027 / 168050 (6.6%) | −110.0 | −108.2 | 0.40 |
| FOXA1 SRX15391842 | T-47D Breast | 256 / 16805 (1.5%) | 8103 / 168050 (4.8%) | −109.9 | −108.0 | 0.32 |
| FOXA3 SRX2630190 | Hep G2 Liver | 394 / 16805 (2.3%) | 10292 / 168050 (6.1%) | −109.8 | −108.0 | 0.38 |
| Epitope tags SRX8080552 | Mammary gland ductal carcinoma Breast | 228 / 16805 (1.4%) | 7629 / 168050 (4.5%) | −109.8 | −107.9 | 0.30 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 137 / 16805 (0.8%) | 6005 / 168050 (3.6%) | −109.8 | −107.9 | 0.23 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 137 / 16805 (0.8%) | 6006 / 168050 (3.6%) | −109.7 | −107.9 | 0.23 |
| ESR1 SRX7624161 | T-47D Breast | 266 / 16805 (1.6%) | 8254 / 168050 (4.9%) | −109.5 | −107.6 | 0.32 |
| FOXA1 SRX5493758 | Breast cancer cells Breast | 328 / 16805 (2.0%) | 9240 / 168050 (5.5%) | −109.1 | −107.2 | 0.35 |
| ESR1 SRX20282945 | MCF-7 Breast | 120 / 16805 (0.7%) | 5660 / 168050 (3.4%) | −109.1 | −107.2 | 0.21 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 309 / 16805 (1.8%) | 8936 / 168050 (5.3%) | −109.1 | −107.2 | 0.35 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 435 / 16805 (2.6%) | 10883 / 168050 (6.5%) | −109.1 | −107.2 | 0.40 |
| ESR1 SRX3080214 | MCF-7 Breast | 114 / 16805 (0.7%) | 5535 / 168050 (3.3%) | −109.0 | −107.1 | 0.21 |
| EP300 SRX1012649 | MCF-7 Breast | 151 / 16805 (0.9%) | 6234 / 168050 (3.7%) | −108.8 | −106.9 | 0.24 |
| TRPS1 SRX3401273 | MCF-7 Breast | 164 / 16805 (1.0%) | 6471 / 168050 (3.9%) | −108.6 | −106.7 | 0.25 |
| FOXA2 SRX8089910 | hESC derived hepatic progenitor Pluripotent stem cell | 1306 / 16805 (7.8%) | 22595 / 168050 (13.4%) | −108.5 | −106.6 | 0.58 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1765 / 16805 (10.5%) | 9769 / 168050 (5.8%) | −108.3 | −106.4 | 1.81 |
| RXRB SRX2636027 | Hep G2 Liver | 500 / 16805 (3.0%) | 11812 / 168050 (7.0%) | −108.2 | −106.4 | 0.42 |
| FOXA2 SRX14524990 | hESC derived pancreatic cells Pluripotent stem cell | 711 / 16805 (4.2%) | 14790 / 168050 (8.8%) | −108.1 | −106.2 | 0.48 |
| FOXA1 SRX15431000 | T-47D Breast | 377 / 16805 (2.2%) | 9964 / 168050 (5.9%) | −108.1 | −106.2 | 0.38 |
| FOXA3 SRX2630189 | Hep G2 Liver | 376 / 16805 (2.2%) | 9944 / 168050 (5.9%) | −107.9 | −106.1 | 0.38 |
| RAD21 SRX2630359 | Liver Liver | 1040 / 16805 (6.2%) | 19167 / 168050 (11.4%) | −107.8 | −105.9 | 0.54 |
| NR3C1 SRX8520802 | HCC1187 Breast | 353 / 16805 (2.1%) | 9579 / 168050 (5.7%) | −107.7 | −105.8 | 0.37 |
| EP300 SRX150579 | HeLa Uterus | 329 / 16805 (2.0%) | 9204 / 168050 (5.5%) | −107.7 | −105.8 | 0.36 |
| ESR1 SRX3123810 | MCF-7 Breast | 101 / 16805 (0.6%) | 5231 / 168050 (3.1%) | −107.5 | −105.6 | 0.19 |
| FOXA1 SRX12971647 | Prostatic Neoplasms, Castration-Resistant Prostate | 323 / 16805 (1.9%) | 9101 / 168050 (5.4%) | −107.4 | −105.6 | 0.35 |
| FOXA1 SRX9550931 | Prostate cancer Prostate | 323 / 16805 (1.9%) | 9101 / 168050 (5.4%) | −107.4 | −105.6 | 0.35 |
| AR SRX10365514 | MCF-7 Breast | 109 / 16805 (0.6%) | 5392 / 168050 (3.2%) | −107.4 | −105.6 | 0.20 |
| FOS SRX4192879 | MCF 10A Breast | 552 / 16805 (3.3%) | 12523 / 168050 (7.5%) | −107.3 | −105.4 | 0.44 |
| FOXA1 SRX5323850 | MCF-7 Breast | 119 / 16805 (0.7%) | 5584 / 168050 (3.3%) | −107.3 | −105.4 | 0.21 |
| FOXA1 SRX10468635 | Breast cancer cells Breast | 394 / 16805 (2.3%) | 10185 / 168050 (6.1%) | −107.1 | −105.2 | 0.39 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 458 / 16805 (2.7%) | 11143 / 168050 (6.6%) | −107.0 | −105.1 | 0.41 |
| ARID1A SRX5089380 | MCF-7 Breast | 177 / 16805 (1.1%) | 6646 / 168050 (4.0%) | −106.8 | −105.0 | 0.27 |
| PGR SRX3990996 | T-47D Breast | 466 / 16805 (2.8%) | 11254 / 168050 (6.7%) | −106.8 | −104.9 | 0.41 |
| FOXA1 SRX1161202 | T-47D Breast | 186 / 16805 (1.1%) | 6805 / 168050 (4.0%) | −106.8 | −104.9 | 0.27 |
| FOXA1 SRX3931083 | MCF-7 Breast | 285 / 16805 (1.7%) | 8467 / 168050 (5.0%) | −106.7 | −104.8 | 0.34 |
| AR SRX1067067 | LHSAR Prostate | 781 / 16805 (4.6%) | 15661 / 168050 (9.3%) | −106.2 | −104.4 | 0.50 |
| ARID1A SRX5089383 | MCF-7 Breast | 122 / 16805 (0.7%) | 5610 / 168050 (3.3%) | −106.2 | −104.4 | 0.22 |
| ESR1 SRX2922233 | SUM 44PE Breast | 514 / 16805 (3.1%) | 11933 / 168050 (7.1%) | −106.2 | −104.3 | 0.43 |
| FOXA1 SRX497612 | VCaP Prostate | 442 / 16805 (2.6%) | 10856 / 168050 (6.5%) | −105.7 | −103.9 | 0.41 |
| Epitope tags SRX1165091 | Hep G2 Liver | 473 / 16805 (2.8%) | 11314 / 168050 (6.7%) | −105.7 | −103.9 | 0.42 |
| RAD21 SRX2630140 | Hep G2 Liver | 473 / 16805 (2.8%) | 11312 / 168050 (6.7%) | −105.6 | −103.7 | 0.42 |
| Epitope tags SRX5577144 | LNCAP Prostate | 436 / 16805 (2.6%) | 10748 / 168050 (6.4%) | −105.3 | −103.4 | 0.41 |
| NR3C1 SRX17639412 | A549 Lung | 526 / 16805 (3.1%) | 12062 / 168050 (7.2%) | −105.2 | −103.3 | 0.44 |
| FOXA1 SRX2642368 | VCaP Prostate | 563 / 16805 (3.4%) | 12594 / 168050 (7.5%) | −105.1 | −103.3 | 0.45 |
| Epitope tags SRX1165108 | MCF-7 Breast | 398 / 16805 (2.4%) | 10171 / 168050 (6.1%) | −105.1 | −103.3 | 0.39 |
| FOXA1 SRX14612991 | T-47D Breast | 161 / 16805 (1.0%) | 6301 / 168050 (3.7%) | −105.0 | −103.2 | 0.26 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 753 / 16805 (4.5%) | 2837 / 168050 (1.7%) | −104.9 | −103.1 | 2.65 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 458 / 16805 (2.7%) | 11061 / 168050 (6.6%) | −104.9 | −103.1 | 0.41 |
| ESR1 SRX176857 | MCF-7 Breast | 164 / 16805 (1.0%) | 6344 / 168050 (3.8%) | −104.7 | −102.9 | 0.26 |
| ESR1 SRX9719169 | MCF-7 Breast | 145 / 16805 (0.9%) | 5997 / 168050 (3.6%) | −104.7 | −102.9 | 0.24 |
| CHD1 SRX116417 | K-562 Blood | 587 / 16805 (3.5%) | 1881 / 168050 (1.1%) | −104.6 | −102.8 | 3.12 |
| FOXA1 SRX5323828 | T-47D Breast | 198 / 16805 (1.2%) | 6940 / 168050 (4.1%) | −104.5 | −102.7 | 0.29 |
| NFIL3 SRX2630334 | Hep G2 Liver | 387 / 16805 (2.3%) | 9981 / 168050 (5.9%) | −104.5 | −102.6 | 0.39 |
| FOXA1 SRX5203311 | MCF-7 Breast | 84 / 16805 (0.5%) | 4790 / 168050 (2.9%) | −104.4 | −102.5 | 0.18 |
| ESR1 SRX8537718 | SUM 44PE Breast | 281 / 16805 (1.7%) | 8317 / 168050 (4.9%) | −104.2 | −102.3 | 0.34 |
| FOXA1 SRX9604647 | LNCAP Prostate | 693 / 16805 (4.1%) | 14369 / 168050 (8.6%) | −104.2 | −102.3 | 0.48 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1161 / 16805 (6.9%) | 5506 / 168050 (3.3%) | −104.1 | −102.3 | 2.11 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 657 / 16805 (3.9%) | 13859 / 168050 (8.2%) | −103.8 | −102.0 | 0.47 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 554 / 16805 (3.3%) | 12410 / 168050 (7.4%) | −103.8 | −102.0 | 0.45 |
| SOX6 SRX10475370 | Hep G2 Liver | 799 / 16805 (4.8%) | 15795 / 168050 (9.4%) | −103.7 | −101.9 | 0.51 |
| ARID1A SRX5089381 | MCF-7 Breast | 196 / 16805 (1.2%) | 6875 / 168050 (4.1%) | −103.6 | −101.8 | 0.29 |
| FOXA1 SRX2642365 | VCaP Prostate | 445 / 16805 (2.6%) | 10817 / 168050 (6.4%) | −103.6 | −101.8 | 0.41 |
| NCOA3 SRX10365550 | MCF-7 Breast | 46 / 16805 (0.3%) | 3916 / 168050 (2.3%) | −103.4 | −101.6 | 0.12 |
| JUN SRX4192884 | MCF 10A Breast | 420 / 16805 (2.5%) | 10436 / 168050 (6.2%) | −103.3 | −101.5 | 0.40 |
| GATA3 SRX6712580 | MCF-7 Breast | 144 / 16805 (0.9%) | 5931 / 168050 (3.5%) | −103.2 | −101.3 | 0.24 |
| GATA3 SRX190194 | SK-N-SH Neural | 1059 / 16805 (6.3%) | 19184 / 168050 (11.4%) | −103.1 | −101.3 | 0.55 |
| NCOA3 SRX10365548 | MCF-7 Breast | 80 / 16805 (0.5%) | 4670 / 168050 (2.8%) | −103.1 | −101.3 | 0.17 |
| FOXA1 SRX10468633 | Breast cancer cells Breast | 380 / 16805 (2.3%) | 9822 / 168050 (5.8%) | −103.0 | −101.2 | 0.39 |
Showing first 500 of 24318 rows.